NCT05916898

Brief Summary

Lower Silesia Shockwave Registry (LSSR), is a observational registry collecting all consecutive cases of percutaneous coronary intervention (PCI) performed with the support of shockwave intravascular lithotripsy in two cooperating cardiac centers (Department of Cardiology, The Copper Health Centre, Lubin Poland, and Department of Cardiology, Provincial Specialized Hospital in Legnica, Poland).

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
400

participants targeted

Target at P75+ for all trials

Timeline
12mo left

Started May 2022

Longer than P75 for all trials

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress80%
May 2022May 2027

Study Start

First participant enrolled

May 1, 2022

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

May 25, 2023

Completed
29 days until next milestone

First Posted

Study publicly available on registry

June 23, 2023

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2026

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2027

Expected
Last Updated

June 23, 2023

Status Verified

June 1, 2023

Enrollment Period

4 years

First QC Date

May 25, 2023

Last Update Submit

June 21, 2023

Conditions

Keywords

Percutaneous coronary interventionsCalcified LesionShockwave intravascular lithotripsyStent under-expansionCoronary artery diseaseslesion preparationstent optimalization

Outcome Measures

Primary Outcomes (2)

  • The Clinical success

    Effective stent deployment or the optimization of previously not fully expanded stent (with less than \<20% in-stent residual stenosis) and the presence of Thrombolysis in Myocardial Infarction (TIMI) 3 flow at the end of the procedure.

    Evaluation at the end of index hospitalization

  • Incidence of Treatment-Emergent Adverse Events

    Safety outcomes were defined as procedural final serious angiographic complications procedural (perforation, abrupt closure, slow flow or no-reflow, unstable ventricular arrhythmias) and device failure (inability to cross the lesion, malfunction, or rapture).

    Evaluation at the end of index hospitalization

Secondary Outcomes (1)

  • Major adverse cardiac and cerebrovascular events (MACCE)

    Final assessment - 5 years after the initial hospitalization; followed by evaluation every 6 months from the end of the hospitalization until the final assessment (5 years).

Study Arms (1)

S-IVL Intervention

Patients with the presence of a highly calcified, resistant lesion or a significantly under-expanded, previously implanted stent (regardless of the time of implantation) were part of the study cohort. The lesion was defined as resistant after an unsuccessful high-pressure NC balloon inflation (at least 20% under-expansion; whit at least 16 atm.). The decision regarding initial lesion preparation was left to the operators' dissertation and did not imply a recruitment process. There were no angiographic exclusion criteria regarding lesion anatomy regarding the length, tortuosity, severity, or prior stent placement. Operators supported by angiography assessment with optional intravascular imagining (IVUS/OCT) determined the size of the S-IVL catheter and an appropriate number of pulses for optimal vessel preparation or management of an under-expanded coronary stent.

Device: PCI with support of Shockwave Intravascular Lithotripsy

Interventions

Coronary artery angioplasty of the primary lesion or optimization of the previously implanted stent with the support of Shockwave Intravascular Lithotripsy device

S-IVL Intervention

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All-commers population with CAD treated by PCI performed with the support of shockwave intravascular lithotripsy.

You may qualify if:

  • The presence of moderately to severely calcified lesions.
  • The presence of significant under-expansion (greater than 20% of the diameter) of the previously implanted stent.
  • Initial failure of the lesion preparation with either the NC balloon catheter or the atherectomy device.

You may not qualify if:

  • Lack of patient consent
  • Target vessel dissection type 3 or higher according to spontaneous coronary artery dissection (SCAD) classification
  • Target vessel perforation due to previous unsuccessful lesion preparation
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Department of Cardiology, Provincial Specialized Hospital in Legnica,

Legnica, Lower Silesian Voivodeship, 59-220, Poland

RECRUITING

Department of Cardiology, The Copper Health Centre (MCZ)

Lubin, Lower Silesian Voivodeship, 59-300, Poland

RECRUITING

Related Publications (1)

  • Rola P, Wlodarczak A, Kulczycki JJ, Barycki M, Furtan L, Szudrowicz M, Jastrzebski A, Pecherzewski M, Doroszko A, Lesiak M. Feasibility of the intravascular lithotripsy in coronary artery disease. Short-term outcomes of the Lower-Silesia Shockwave Registry. Kardiol Pol. 2021;79(10):1133-1135. doi: 10.33963/KP.a2021.0093. Epub 2021 Aug 20. No abstract available.

MeSH Terms

Conditions

Coronary Artery Disease

Interventions

Percutaneous Coronary Intervention

Condition Hierarchy (Ancestors)

Coronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular Diseases

Intervention Hierarchy (Ancestors)

Endovascular ProceduresVascular Surgical ProceduresCardiovascular Surgical ProceduresSurgical Procedures, OperativeMinimally Invasive Surgical Procedures

Central Study Contacts

Adrian Włodarczak, M.D; Ph. D; Assoc Prof.

CONTACT

Piotr Rola, M.D.; Ph.D.

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Target Duration
5 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
M.D.; Ph.D. Assoc Prof.

Study Record Dates

First Submitted

May 25, 2023

First Posted

June 23, 2023

Study Start

May 1, 2022

Primary Completion

May 1, 2026

Study Completion (Estimated)

May 1, 2027

Last Updated

June 23, 2023

Record last verified: 2023-06

Locations